Inflammatory processes may play role in ALS

Amyotrophic lateral sclerosis (ALS), perhaps more commonly known as Lou Gehrig’s disease, is a devastating neurological disease that ultimately leads to death.  This disease eats away at nerve cells, causing death to the motor neurons in

Christian Hoyer Millar, Chief Executive Officer of Oxford BioDynamics, said: “Bartu Ahiska has an exceptional track record as an entrepreneur in the creation and commercialisation of intellectual property, as well as an impeccable academic background. We

June is Motor Neurone Disease (MND) awareness month- MND describes a disease that affects the nerves in the brain and spinal cord that tell your muscles what to do. MND stops the messages from the nerves

An independent research organization reported that donations from the 2014 ALS Ice Bucket Challenge enabled The ALS Association to increase its annual funding for research around the world by 187 percent. During this time, ALS researchers

Multiple Sclerosis (MS) is a lifelong autoimmune condition that affects the brain and the spinal cord, resulting in a wide range of symptoms that vary from person-to-person. Depending on the severity, MS can be debilitating, leading

Oxford BioDynamics Plc (LON: OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today announced its interim results for

A TARGETED ANSWER TO CANCER Like many patients and caregivers on a cancer treatment journey, you may be familiar with traditional treatments such as chemotherapy and radiation. Several important features of immunotherapy make for a more

Clinicians can reliably diagnose autism in some toddlers roughly two years earlier than the typical age of diagnosis, a new study suggests. The researchers assessed more than 1,200 toddlers for autism at least twice using standard

Men with prostate cancer are three times more likely to die from it if they have a particular genetic mutation. Up to one in five patients may have a genetic quirk which worsens their chances of

Oxford BioDynamics Plc (LON:OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today announced that it has been selected

Oxford BioDynamics Plc (LON: OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, is pleased to note today’s announcement

How I agree with Jim Cosgrove’s moving letter about the perils of classifying children and young people into categories and the desirability of an inclusive approach to all manifestations of the human experience. However, as the

Christopher Timothy, 78, became a regular on the BBC’s EastEnders in April 2017. The role came after a long career in TV, having also played James Herriot in All Creatures Great and Small and Brendan “Mac”

Christian Hoyer Millar, Chief Executive Officer of Oxford BioDynamics, said: “We are delighted to have been chosen for such a prestigious award, which is an outstanding achievement for the Company. This award is recognised worldwide as

Type 2 diabetes is a common condition in the UK that can be caused by eating a poor diet, high in saturated fat. Left untreated, it can lead to serious, long-term health problems, such as cardiovascular

Cancer symptoms are often caused by something less serious, but there’s still a chance it could be a sign of the condition. Any changes in the body should be checked out by a GP. Spotting cancer

Melanoma is the most severe form of skin cancer, and it occurs in the cells responsible for producing melanin (melanocytes). Although it primarily affects the skin, it is also known to form in the eyes and,

Oxford BioDynamics Plc (LON: OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today announces, further to the announcement